YD Bio Limited (YDES)

YD Bio Limited is a biotechnology company whose ordinary shares trade on the Nasdaq. The company became publicly listed through a business combination with a special purpose acquisition company.

YD Bio focuses on diagnostic and therapeutic technologies, with an emphasis on molecular testing such as DNA methylation-based approaches for the early detection of cancer, along with related healthcare products. Its operations have ties to Taiwan and Asia, and further details on its pipeline, partnerships and headquarters are provided in its SEC filings.